Increased malignancies in our Waikato cohort of patients with systemic sclerosis.

Background: Systemic sclerosis (SSc) has been associated with an increased risk of malignancy (especially in the skin, lung, breast, and hematological system).

Aim: To determine the risk of malignancies in our SSc cohort.

Methods: The NZ National Cancer Registry supplied details of all malignancies recorded in patients attending the Waikato Hospital Systemic Sclerosis Clinics from 2005 to 2018.